SCHEMBL3168677

SCHEMBL3168677

CC(=O)NCCNc1cc(NCCNC(=O)c2ccc(C(=O)C(F)(F)F)cc2)nc(-c2ccccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 6/20 0.51
CYP1A2 P05177 7/20 0.47
CYP3A4 P08684 6/20 0.47
ALDH1A1 P00352 5/20 0.47
CLK4 Q9HAZ1 5/20 0.47
HSD17B10 Q99714 3/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
ADORA2A P29274 2/20 0.44
ADORA1 P30542 2/20 0.44
ALOX15 P16050 2/20 0.43
MAPK1 P28482 2/20 0.43
TSHR P16473 4/20 0.42
CYP2D6 P10635 3/20 0.42
ADORA3 P0DMS8 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163102 0.90 MLYCD (0.46) MLYCDCYP1A2CYP3A4ALDH1A1CLK4
SCHEMBL3163394 0.89 ADORA1 (0.51) CYP1A2CYP3A4ALDH1A1CLK4HSD17B10
SCHEMBL3168663 0.88 ADORA1 (0.48) CYP1A2CYP3A4ALDH1A1CLK4HSD17B10
SCHEMBL3156240 0.87 RAB9A (0.51) CYP1A2CYP3A4ALDH1A1CLK4HSD17B10
SCHEMBL3162824 0.87 ADORA1 (0.47) CYP1A2CYP3A4ALDH1A1CLK4HSD17B10
SCHEMBL3165176 0.87 POLB (0.57) CYP1A2CYP3A4ALDH1A1CLK4HSD17B10
SCHEMBL3171511 0.87 ADORA3 (0.51) CYP1A2CYP3A4ALDH1A1CLK4HSD17B10
SCHEMBL3166454 0.86 ADORA2A (0.56) MLYCDCYP1A2CYP3A4ALDH1A1CLK4
SCHEMBL3168745 0.85 ADORA2A (0.56) CYP1A2CYP3A4ALDH1A1CLK4HSD17B10
SCHEMBL3170298 0.85 ADORA2A (0.46) CYP1A2CYP3A4ALDH1A1CLK4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed